L
LequteMan
Guest
The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday.
"After his or her injection, each volunteer was kept under observation for 1.5 hours at the clinical trials unit," scientists at the Swiss hospital said in a statement.
"To date, no major side effects have been observed after the injections, which triggered the expected inflammatory responses. They (the inflammatory responses) have been weak to moderate, with limited cases of mild fever," it added.
Since 10 November, 34 volunteers have been vaccinated with the shot, known as VSV-ZEBOV Ebola vaccine, at the request of the World Health Organization (WHO), REUTERS reports.
The shot, one of several being fast-tracked through clinical trials in the hope they can be approved for use in the Ebola epidemic raging in West Africa, is undergoing initial human safety tests at the University Hospitals of Geneva.
Trials have also begun in the United States, Canada, Germany and Gabon, and similar trials should start soon in Kenya.
The Ebola virus has been ravaging West Africa for the past few months with over 7,0o0 people dead from the virus and more than 15,000 infected.
#Ebola #Vaccine
"After his or her injection, each volunteer was kept under observation for 1.5 hours at the clinical trials unit," scientists at the Swiss hospital said in a statement.
"To date, no major side effects have been observed after the injections, which triggered the expected inflammatory responses. They (the inflammatory responses) have been weak to moderate, with limited cases of mild fever," it added.
Since 10 November, 34 volunteers have been vaccinated with the shot, known as VSV-ZEBOV Ebola vaccine, at the request of the World Health Organization (WHO), REUTERS reports.
The shot, one of several being fast-tracked through clinical trials in the hope they can be approved for use in the Ebola epidemic raging in West Africa, is undergoing initial human safety tests at the University Hospitals of Geneva.
Trials have also begun in the United States, Canada, Germany and Gabon, and similar trials should start soon in Kenya.
The Ebola virus has been ravaging West Africa for the past few months with over 7,0o0 people dead from the virus and more than 15,000 infected.
#Ebola #Vaccine